Sign In | Join Free | My tjskl.org.cn
China Walvax Biotechnology Co., Ltd. logo
Walvax Biotechnology Co., Ltd.
Help Everyone Live a Healthy Life!
Verified Supplier

1 Years

Home > 23-Valent Pneumococcal Polysaccharide Vaccine >

Kids Liquid 23-Valent Pneumococcal Polysaccharide Vaccine

Walvax Biotechnology Co., Ltd.
Trust Seal
Verified Supplier
Credit Check
Supplier Assessment

Kids Liquid 23-Valent Pneumococcal Polysaccharide Vaccine

Brand Name : Walvax

Model Number : 23-valent Pneumococcal Polysaccharide Vaccine

Certification : Certificated by China

Place of Origin : China

Payment Terms : L/C, T/T

Delivery Time : In stock: 20 workdays; To be produced: 4-5 months

Packaging Details : Prefilled syringe, 1 dose

Presentation : Prefilled syringe, 1 dose

Eligibles : This vaccine is indicated for use in persons aged ≥ 2 years who are at increased risk of pneumococcal disease.

Schedule : ≥2 year: 1 does, inject intramuscularly or subcutaneously into the deltoid of the lateral upper arm(intramuscularly recommended).

Shelf Life : 24 months at 2-8℃.

Dosage Form : Prefilled syringe

Package : 1 syringe per box

Contact Now

Product Discription (PPSV23)

This vaccine is produced by culture, extraction and purification of polysaccharide antigens of 23 epidemic and infectious Streptococcus pneumoniae serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F. No preservatives added.

Composition

Each dose of 23-valent Pneumococcal Polysaccharide Vaccine (PPSV23) contains:

Polysaccharide of each pneumococcal serotype…………..…………25 μg

Sodium chloride…............................................................................4.25mg

Disodium hydrogen phosphate………………………………………..35.5 μg

Sodium dihydrogen phosphate……………………………………….….30 μg

Water for Injection………………………………....……………………..0.5 ml

Eligibles

This vaccine is indicated for use in persons aged ≥ 2 years who are at increased risk of pneumococcal disease. Specially recommended populations:

- Elderly persons;

- Patients with normal immunologic functions but suffer from chronic diseases (cardiovascular disease, pulmonary disease, diabetes, alcohol intoxication and hepatocirrhosis);

- Patients with immunodeficiency: splenectomy or splenic dysfunction, sickle cell disease, Hodgkin’s diseases, lymphoma, multiple myeloma, chronic renal failure, nephrotic syndrome and organ transplantation;

- Patients with asymptomatic and symptomatic HIV infection;

- Persons with cerebrospinal fluid leakage;

- Special populations: persons who are living in environment or social settings in which the risk for invasive pneumococcal disease or its complications is increased (e.g. elderly with long hospitalization, residents of nursing homes and other long-term care facilities).

Indication

The vaccine is indicated for active immunization to prevent pneumococcal disease caused by the 23 serotypes contained in the vaccine(1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F). The vaccine is approved for use in persons 2 years of age and older. It does not protect against diseases caused by Streptococcus pneumoniae serotypes that are not contained in the vaccine.

Aderse Reactions

The incidence rates of adverse reactions reported in clinical trials, according to the guidance on classifications of adverse events recommended by The Council for International Organizations of Medical Sciences (CIOMS), are classified as: very common (≥10%), common (≥1% to <10%,), uncommon (≥0.1% to <1%), rare (≥0.01% to <0.1%) and very rare (<0.01%) as following:

Very common:

Pain at injection site (mild, transient)

Common:

(1) Reactions at injection site: redness, swelling, itching.

(2) Systemic reactions: fever, fatigue, headache, diarrhea.

Uncommon:

(1) Reactions at injection site: induration.

(2) Systemic reactions: vomiting, rash, allergy.

Presentation

Liquid,1 dose/PFS,0.5ml/dose.

Schedule

≥2 year:1 does, inject intramuscularly or subcutaneously into the deltoid of the lateral upper arm (intramuscularly recommended).

Shelf Life

24 months at 2-8℃.


Product Tags:

Liquid 23-Valent Pneumococcal Polysaccharide Vaccine

      

Kids 23-Valent Pneumococcal Polysaccharide Vaccine

      

Kids PPSV23 Pneumococcal Vaccine

      
Quality Kids Liquid 23-Valent Pneumococcal Polysaccharide Vaccine for sale

Kids Liquid 23-Valent Pneumococcal Polysaccharide Vaccine Images

Inquiry Cart 0
Send your message to this supplier
 
*From:
*To: Walvax Biotechnology Co., Ltd.
*Subject:
*Message:
Characters Remaining: (0/3000)